Durey H Peterson

Title: Durey H Peterson: Innovator in Antibiotic Development

Introduction

Durey H Peterson is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of antibiotic development, holding 2 patents that focus on novel antibiotic formulations. His work has the potential to impact both human and animal health by addressing infections caused by Gram-negative bacteria.

Latest Patents

Peterson's latest patents include the development of Antibiotic 354 and a process for producing the same. This novel antibiotic, designated as U-54,703, is produced through fermentation under controlled conditions using the microorganism Streptomyces puniceus subsp. doliceus, NRRL 11160. Antibiotic 354 is particularly effective against Gram-negative bacteria, such as Pseudomonas and Proteus species. This makes it a valuable tool for eradicating or controlling these bacteria in various environments. Additionally, he has developed formulations of antibiotic 354 for treating susceptible infectious diseases in both humans and animals.

Career Highlights

Durey H Peterson has had a distinguished career at The Upjohn Company, where he has focused on antibiotic research and development. His innovative approaches have led to advancements in the treatment of bacterial infections, showcasing his commitment to improving health outcomes.

Collaborations

Throughout his career, Peterson has collaborated with notable colleagues, including Lester A Dolak and Clarence DeBoer. These partnerships have contributed to the successful development of his patented antibiotics and have fostered a collaborative environment for innovation.

Conclusion

Durey H Peterson's contributions to antibiotic development highlight his role as a significant inventor in the field. His work not only addresses critical health challenges but also exemplifies the importance of innovation in medical science.